Ibrutinib is used to treat chronic lymphocytic leukemia Waldenström's macroglobulinemia, and as a second-line treatment for mantle cell lymphoma, marginal zone lymphoma, and chronic graft vs host disease. It is a small molecule drug. Reference standards of Ibrutinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => 1-(1-Nitrosopiperidin-3-yl)-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine [catalogue_number] => PA 09 0271021 [category_ids] => ,70,71,78,82,162, [chemical_name] => [weight] => 415.46 [form] => C22H21N7O2 [cas] => 2256059-43-3 [pslug] => 2256059-43-3-1-1-nitrosopiperidin-3-yl-3-4-phenoxyphenyl-1h-pyrazolo-3-4-d-pyrimidin-4-amine-pa090271021 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 09 0271021
CAS :
Molecular Formula : C22H21N7O2
Molecular Weight : 415.46
stdClass Object ( [pname] => (R)-1-(1-Nitrosopiperidin-3-yl)-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine [catalogue_number] => PA 09 0271027 [category_ids] => ,79,80,81,78,162, [chemical_name] => [weight] => 415.46 [form] => C22H21N7O2 [cas] => NA [pslug] => r-1-1-nitrosopiperidin-3-yl-3-4-phenoxyphenyl-1h-pyrazolo-3-4-d-pyrimidin-4-amine-pa090271027 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 09 0271027
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
